speb/financial-data huggingface dataset:
CRGO balance_sheet (quarterly, 2025-09-30) — Share Issued: 50595118.00
CRGO cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 845000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 44715000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 21954000.00
CRGO income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -158340.00
CRGO income_statement (quarterly, 2025-09-30) — Tax Provision: 30000.00
CRGO income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CRGO cash_flow (quarterly, 2025-09-30) — Taxes Refund Paid: -23000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Total Assets: 67118000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 44715000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Total Debt: 1768000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 44715000.00
CRGO income_statement (quarterly, 2025-09-30) — Total Expenses: 12010000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 22403000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 27059000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 2528000.00
CRGO income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -4338000.00
CRGO income_statement (quarterly, 2025-09-30) — Total Unusual Items: -754000.00
CRGO income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -754000.00
CRGO balance_sheet (quarterly, 2025-09-30) — Working Capital: 20184000.00
CRGO income_statement (annual, 2025-12-31) — +Operating Expense: 38839000.00
CRGO income_statement (quarterly, 2025-12-31) — +Operating Expense: 10370000.00
CRGO income_statement (annual, 2025-12-31) — +Total Revenue: 29460000.00
CRGO income_statement (quarterly, 2025-12-31) — +Total Revenue: 7405000.00
CRGO balance_sheet (annual, 2025-12-31) — Accounts Payable: 5103000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 5103000.00
CRGO balance_sheet (annual, 2025-12-31) — Accounts Receivable: 3773000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 3773000.00
CRGO balance_sheet (annual, 2025-12-31) — Accrued Interest Receivable: 33000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Accrued Interest Receivable: 33000.00
CRGO balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -4150000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -4150000.00
CRGO balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 266583000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 266583000.00
CRGO balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -177000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -177000.00
CRGO cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 2453000.00
CRGO cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 2453000.00
CRGO cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 0.00
CRGO income_statement (annual, 2025-12-31) — Basic Average Shares: 50573461.00
CRGO income_statement (quarterly, 2025-12-31) — Basic Average Shares: 51214592.00
CRGO income_statement (annual, 2025-12-31) — Basic EPS: -0.35
CRGO income_statement (quarterly, 2025-12-31) — Basic EPS: -0.07
CRGO cash_flow (annual, 2025-12-31) — Beginning Cash Position: 10118000.00
CRGO cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 16290000.00
CRGO balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 5054000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 5054000.00
CRGO cash_flow (annual, 2025-12-31) — Capital Expenditure: -135000.00
CRGO cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -18000.00
CRGO balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 2372000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 2372000.00
CRGO balance_sheet (annual, 2025-12-31) — Capital Stock: 1000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Capital Stock: 1000.00
CRGO balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 13347000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 13347000.00
CRGO balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 27893000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 27893000.00
CRGO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -22000.00
CRGO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -78000.00
CRGO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 11629000.00
CRGO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -93000.00
CRGO cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -8868000.00
CRGO cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2951000.00
CRGO cash_flow (annual, 2025-12-31) — Change In Account Payable: 2294000.00
CRGO cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -249000.00
CRGO cash_flow (annual, 2025-12-31) — Change In Accrued Expense: -1060000.00
CRGO cash_flow (quarterly, 2025-12-31) — Change In Accrued Expense: -798000.00
CRGO cash_flow (annual, 2025-12-31) — Change In Other Current Assets: 1674000.00
CRGO cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 188000.00
CRGO cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -1674000.00
CRGO cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -188000.00
CRGO cash_flow (annual, 2025-12-31) — Change In Payable: 2294000.00
CRGO cash_flow (quarterly, 2025-12-31) — Change In Payable: -249000.00
CRGO cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 1234000.00
CRGO cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -1047000.00
CRGO cash_flow (annual, 2025-12-31) — Change In Receivables: -452000.00
CRGO cash_flow (quarterly, 2025-12-31) — Change In Receivables: 910000.00
CRGO cash_flow (annual, 2025-12-31) — Change In Working Capital: 782000.00
CRGO cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -137000.00
CRGO cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -521000.00
CRGO cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 498000.00
CRGO cash_flow (annual, 2025-12-31) — Changes In Cash: 2739000.00
CRGO cash_flow (quarterly, 2025-12-31) — Changes In Cash: -3122000.00
CRGO balance_sheet (annual, 2025-12-31) — Common Stock: 1000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Common Stock: 1000.00
CRGO balance_sheet (annual, 2025-12-31) — Common Stock Equity: 42922000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 42922000.00
CRGO cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
CRGO income_statement (annual, 2025-12-31) — Cost Of Revenue: 9777000.00
CRGO income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 2658000.00
CRGO balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 2541000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2541000.00
CRGO balance_sheet (annual, 2025-12-31) — Current Assets: 36109000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Current Assets: 36109000.00
CRGO balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 627000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 627000.00
CRGO balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 627000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 627000.00
CRGO balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 2842000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 2842000.00
CRGO balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 2842000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 2842000.00
CRGO balance_sheet (annual, 2025-12-31) — Current Liabilities: 16754000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 16754000.00
CRGO cash_flow (annual, 2025-12-31) — Deferred Income Tax: 146000.00
CRGO cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 23000.00
CRGO cash_flow (annual, 2025-12-31) — Deferred Tax: 146000.00
CRGO cash_flow (quarterly, 2025-12-31) — Deferred Tax: 23000.00
CRGO cash_flow (annual, 2025-12-31) — Depreciation: 996000.00
CRGO cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3449000.00
CRGO cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 843000.00
CRGO income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 1560000.00
CRGO cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3449000.00
CRGO cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 843000.00
CRGO income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 1560000.00
CRGO income_statement (annual, 2025-12-31) — Diluted Average Shares: 50573461.00
CRGO income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 51214592.00
CRGO income_statement (annual, 2025-12-31) — Diluted EPS: -0.35
CRGO income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.07
CRGO income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -17516000.00
CRGO income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -3777000.00
CRGO income_statement (annual, 2025-12-31) — EBIT: -17102000.00
CRGO income_statement (quarterly, 2025-12-31) — EBIT: -3693000.00
CRGO income_statement (annual, 2025-12-31) — EBITDA: -13653000.00
CRGO income_statement (quarterly, 2025-12-31) — EBITDA: -2850000.00
CRGO cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 490000.00
CRGO cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 179000.00
CRGO balance_sheet (annual, 2025-12-31) — Employee Benefits: 1275000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 1275000.00
CRGO cash_flow (annual, 2025-12-31) — End Cash Position: 13347000.00
CRGO cash_flow (quarterly, 2025-12-31) — End Cash Position: 13347000.00
CRGO cash_flow (annual, 2025-12-31) — Financing Cash Flow: -22000.00
CRGO cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -78000.00
CRGO balance_sheet (annual, 2025-12-31) — Foreign Currency Translation Adjustments: 288000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Foreign Currency Translation Adjustments: 288000.00
CRGO cash_flow (annual, 2025-12-31) — Free Cash Flow: -9003000.00
CRGO cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -2969000.00
CRGO cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -227000.00
CRGO cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -1489000.00
CRGO income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 227000.00
CRGO income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 1489000.00
CRGO balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 524000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 524000.00
CRGO income_statement (annual, 2025-12-31) — General And Administrative Expense: 21783000.00
CRGO income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 13326000.00
CRGO balance_sheet (annual, 2025-12-31) — Goodwill: 14809000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Goodwill: 14809000.00
CRGO balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 21601000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 21601000.00
CRGO balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 3950000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 3950000.00
CRGO balance_sheet (annual, 2025-12-31) — Gross PPE: 6749000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Gross PPE: 6749000.00
CRGO income_statement (annual, 2025-12-31) — Gross Profit: 19683000.00
CRGO income_statement (quarterly, 2025-12-31) — Gross Profit: 4747000.00
CRGO income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 0.00
CRGO income_statement (annual, 2025-12-31) — Insurance And Claims: 691000.00
CRGO income_statement (annual, 2025-12-31) — Interest Expense: 268000.00
CRGO income_statement (quarterly, 2025-12-31) — Interest Expense: 61000.00
CRGO income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 268000.00
CRGO income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 61000.00
CRGO income_statement (annual, 2025-12-31) — Interest Income: 1827000.00
CRGO income_statement (quarterly, 2025-12-31) — Interest Income: 441000.00
CRGO income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1827000.00
CRGO income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 441000.00
CRGO cash_flow (annual, 2025-12-31) — Interest Received Cfo: 1791000.00
CRGO cash_flow (quarterly, 2025-12-31) — Interest Received Cfo: 61000.00
CRGO balance_sheet (annual, 2025-12-31) — Invested Capital: 42922000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Invested Capital: 42922000.00
CRGO cash_flow (annual, 2025-12-31) — Investing Cash Flow: 11629000.00
CRGO cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -93000.00
CRGO cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
CRGO balance_sheet (annual, 2025-12-31) — Leases: 402000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Leases: 402000.00
CRGO balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 1745000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 1745000.00
CRGO balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1745000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 1745000.00
CRGO cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -704000.00
CRGO cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -177000.00
CRGO balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1248000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1248000.00
CRGO balance_sheet (annual, 2025-12-31) — Minimum Pension Liabilities: 236000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Minimum Pension Liabilities: 236000.00
CRGO cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 0.00
CRGO cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
CRGO cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
CRGO income_statement (annual, 2025-12-31) — Net Income: -17516000.00
CRGO income_statement (quarterly, 2025-12-31) — Net Income: -3777000.00
CRGO income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -17516000.00
CRGO income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -3777000.00
CRGO income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -17516000.00
CRGO income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -3777000.00
CRGO income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -17516000.00
CRGO income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -3777000.00
CRGO income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -17516000.00
CRGO income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -3777000.00
CRGO cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -17516000.00
CRGO cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -3777000.00
CRGO income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -17516000.00
CRGO income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -3777000.00
CRGO income_statement (annual, 2025-12-31) — Net Interest Income: 1559000.00
CRGO income_statement (quarterly, 2025-12-31) — Net Interest Income: 380000.00
CRGO cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 11738000.00
CRGO cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -75000.00
CRGO cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -704000.00
CRGO cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -177000.00
CRGO cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -704000.00
CRGO cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -177000.00
CRGO income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 1559000.00
CRGO income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 380000.00
CRGO balance_sheet (annual, 2025-12-31) — Net PPE: 2599000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Net PPE: 2599000.00
CRGO cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -109000.00
CRGO cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -18000.00
CRGO cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
CRGO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 21321000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 21321000.00
CRGO balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 560000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 560000.00
CRGO balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 560000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 560000.00
CRGO balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1275000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 1275000.00
CRGO balance_sheet (annual, 2025-12-31) — Non Current Prepaid Assets: 1827000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Non Current Prepaid Assets: 1827000.00
CRGO income_statement (annual, 2025-12-31) — Normalized EBITDA: -13880000.00
CRGO income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -4339000.00
CRGO income_statement (annual, 2025-12-31) — Normalized Income: -17695330.00
CRGO income_statement (quarterly, 2025-12-31) — Normalized Income: -4953310.00
CRGO cash_flow (annual, 2025-12-31) — Operating Cash Flow: -8868000.00
CRGO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -2951000.00
CRGO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -227000.00
CRGO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -1489000.00
CRGO income_statement (annual, 2025-12-31) — Operating Income: -19156000.00
CRGO income_statement (quarterly, 2025-12-31) — Operating Income: -5623000.00
CRGO income_statement (annual, 2025-12-31) — Operating Revenue: 29460000.00
CRGO income_statement (quarterly, 2025-12-31) — Operating Revenue: 7405000.00
CRGO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 51376890.00
CRGO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 51376890.00
CRGO balance_sheet (annual, 2025-12-31) — Other Current Assets: 2884000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 2884000.00
CRGO balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 5107000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 5107000.00
CRGO income_statement (annual, 2025-12-31) — Other Gand A: 3558000.00
CRGO income_statement (quarterly, 2025-12-31) — Other Gand A: -4899000.00
CRGO income_statement (annual, 2025-12-31) — Other Income Expense: 227000.00
CRGO income_statement (quarterly, 2025-12-31) — Other Income Expense: 1489000.00
CRGO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 6792000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 6792000.00
CRGO cash_flow (annual, 2025-12-31) — Other Non Cash Items: -1559000.00
CRGO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -380000.00
CRGO balance_sheet (annual, 2025-12-31) — Other Payable: 534000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Other Payable: 534000.00
CRGO balance_sheet (annual, 2025-12-31) — Other Receivables: 692000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Other Receivables: 692000.00
CRGO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 14546000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 14546000.00
CRGO balance_sheet (annual, 2025-12-31) — Payables: 5637000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Payables: 5637000.00
CRGO balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 8178000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 8178000.00
CRGO balance_sheet (annual, 2025-12-31) — Prepaid Assets: 834000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 834000.00
CRGO income_statement (annual, 2025-12-31) — Pretax Income: -17370000.00
CRGO income_statement (quarterly, 2025-12-31) — Pretax Income: -3754000.00
CRGO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 682000.00
CRGO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 99000.00
CRGO cash_flow (annual, 2025-12-31) — Purchase Of Business: 0.00
CRGO cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
CRGO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -14378000.00
CRGO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -14075000.00
CRGO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -135000.00
CRGO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -18000.00
CRGO balance_sheet (annual, 2025-12-31) — Receivables: 4498000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Receivables: 4498000.00
CRGO income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 7888000.00
CRGO income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2658000.00
CRGO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 3449000.00
CRGO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 843000.00
CRGO income_statement (annual, 2025-12-31) — Rent And Landing Fees: 584000.00
CRGO income_statement (annual, 2025-12-31) — Rent Expense Supplemental: 584000.00
CRGO cash_flow (annual, 2025-12-31) — Repayment Of Debt: -704000.00
CRGO cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -177000.00
CRGO income_statement (annual, 2025-12-31) — Research And Development: 11942000.00
CRGO income_statement (quarterly, 2025-12-31) — Research And Development: 3186000.00
CRGO income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CRGO balance_sheet (annual, 2025-12-31) — Retained Earnings: -224186000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -224186000.00
CRGO income_statement (annual, 2025-12-31) — Salaries And Wages: 16950000.00
CRGO cash_flow (annual, 2025-12-31) — Sale Of Investment: 26116000.00
CRGO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 14000000.00
CRGO cash_flow (annual, 2025-12-31) — Sale Of PPE: 26000.00
CRGO cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 0.00
CRGO income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 3554000.00
CRGO income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: -7702000.00
CRGO income_statement (annual, 2025-12-31) — Selling General And Administration: 25337000.00
CRGO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 5624000.00
CRGO balance_sheet (annual, 2025-12-31) — Share Issued: 51376890.00
CRGO balance_sheet (quarterly, 2025-12-31) — Share Issued: 51376890.00
CRGO cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00
CRGO income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
CRGO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 4306000.00
CRGO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1953000.00
CRGO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 42922000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 42922000.00
CRGO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 21321000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 21321000.00
CRGO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 47670.00
CRGO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 312690.00
CRGO income_statement (annual, 2025-12-31) — Tax Provision: 146000.00
CRGO income_statement (quarterly, 2025-12-31) — Tax Provision: 23000.00
CRGO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
CRGO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CRGO cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -40000.00
CRGO cash_flow (quarterly, 2025-12-31) — Taxes Refund Paid: -48000.00
CRGO balance_sheet (annual, 2025-12-31) — Total Assets: 62696000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Total Assets: 62696000.00
CRGO balance_sheet (annual, 2025-12-31) — Total Capitalization: 42922000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 42922000.00
CRGO balance_sheet (annual, 2025-12-31) — Total Debt: 2372000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Total Debt: 2372000.00
CRGO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 42922000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 42922000.00
CRGO income_statement (annual, 2025-12-31) — Total Expenses: 48616000.00
CRGO income_statement (quarterly, 2025-12-31) — Total Expenses: 13028000.00
CRGO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 19774000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 19774000.00
CRGO balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 26587000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 26587000.00
CRGO balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3020000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 3020000.00
CRGO income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -19156000.00
CRGO income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -5623000.00
CRGO income_statement (annual, 2025-12-31) — Total Unusual Items: 227000.00
CRGO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 1489000.00
CRGO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 227000.00
CRGO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 1489000.00
CRGO balance_sheet (annual, 2025-12-31) — Working Capital: 19355000.00
CRGO balance_sheet (quarterly, 2025-12-31) — Working Capital: 19355000.00
CRGO income_statement (quarterly, 2026-03-31) — +Operating Expense: 9507000.00
CRGO income_statement (quarterly, 2026-03-31) — +Total Revenue: 7156000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 3564000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3541000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 267687000.00
CRGO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 51527502.00
CRGO income_statement (quarterly, 2026-03-31) — Basic EPS: -0.13
CRGO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 13347000.00
CRGO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -17000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 2296000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 1000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 8763000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 23494000.00
CRGO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: -176000.00
CRGO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -11000.00
CRGO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -4463000.00
CRGO cash_flow (quarterly, 2026-03-31) — Change In Account Payable: -1510000.00
CRGO cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: 974000.00
CRGO cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -354000.00
CRGO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 354000.00
CRGO cash_flow (quarterly, 2026-03-31) — Change In Payable: -1510000.00
CRGO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -536000.00
CRGO cash_flow (quarterly, 2026-03-31) — Change In Receivables: 286000.00
CRGO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -250000.00
CRGO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: 181000.00
CRGO cash_flow (quarterly, 2026-03-31) — Changes In Cash: -4650000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Common Stock: 1000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 37452000.00
CRGO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2388000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 7157000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Current Assets: 31611000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 633000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 633000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 17097000.00
CRGO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 93000.00
CRGO cash_flow (quarterly, 2026-03-31) — Deferred Tax: 93000.00
CRGO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 842000.00
CRGO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 842000.00
CRGO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 51527502.00
CRGO income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.13
CRGO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -6461000.00
CRGO income_statement (quarterly, 2026-03-31) — EBIT: -6307000.00
CRGO income_statement (quarterly, 2026-03-31) — EBITDA: -5465000.00
CRGO cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 66000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 1176000.00
CRGO cash_flow (quarterly, 2026-03-31) — End Cash Position: 8763000.00
CRGO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -176000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Foreign Currency Translation Adjustments: 175000.00
CRGO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -4480000.00
CRGO cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 301000.00
CRGO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -301000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 411000.00
CRGO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 3009000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Goodwill: 14759000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 20868000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2544000.00
CRGO income_statement (quarterly, 2026-03-31) — Gross Profit: 4768000.00
CRGO income_statement (quarterly, 2026-03-31) — Interest Expense: 61000.00
CRGO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 61000.00
CRGO income_statement (quarterly, 2026-03-31) — Interest Income: 221000.00
CRGO income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 221000.00
CRGO cash_flow (quarterly, 2026-03-31) — Interest Received Cfo: 16000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 37452000.00
CRGO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -11000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 1663000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1663000.00
CRGO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -219000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Minimum Pension Liabilities: 236000.00
CRGO income_statement (quarterly, 2026-03-31) — Net Income: -6461000.00
CRGO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -6461000.00
CRGO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -6461000.00
CRGO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -6461000.00
CRGO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -6461000.00
CRGO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -6461000.00
CRGO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -6461000.00
CRGO income_statement (quarterly, 2026-03-31) — Net Interest Income: 160000.00
CRGO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 6000.00
CRGO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -219000.00
CRGO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -219000.00
CRGO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 160000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Net PPE: 2544000.00
CRGO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -17000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 16584000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 557000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 557000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 1176000.00
CRGO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -3676000.00
CRGO income_statement (quarterly, 2026-03-31) — Normalized Income: -5387600.00
CRGO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -4463000.00
CRGO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 301000.00
CRGO income_statement (quarterly, 2026-03-31) — Operating Income: -4739000.00
CRGO income_statement (quarterly, 2026-03-31) — Operating Revenue: 7156000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 51376890.00
CRGO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 3219000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 5743000.00
CRGO income_statement (quarterly, 2026-03-31) — Other Gand A: 3009000.00
CRGO income_statement (quarterly, 2026-03-31) — Other Income Expense: -1789000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 6109000.00
CRGO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -160000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 1808000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Other Properties: 2544000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 1357000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 14731000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Payables: 3564000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 10721000.00
CRGO income_statement (quarterly, 2026-03-31) — Pretax Income: -6368000.00
CRGO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 43000.00
CRGO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -17000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Receivables: 4898000.00
CRGO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 2388000.00
CRGO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 842000.00
CRGO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -219000.00
CRGO income_statement (quarterly, 2026-03-31) — Research And Development: 2923000.00
CRGO income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 1488000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -230647000.00
CRGO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 6000.00
CRGO cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
CRGO income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 3575000.00
CRGO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 6584000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Share Issued: 51376890.00
CRGO income_statement (quarterly, 2026-03-31) — Special Income Charges: -1488000.00
CRGO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1061000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 37452000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 16584000.00
CRGO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -715600.00
CRGO income_statement (quarterly, 2026-03-31) — Tax Provision: 93000.00
CRGO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CRGO cash_flow (quarterly, 2026-03-31) — Taxes Refund Paid: 95000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Total Assets: 57388000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 37452000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Total Debt: 2296000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 37452000.00
CRGO income_statement (quarterly, 2026-03-31) — Total Expenses: 11895000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 19936000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 25777000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2839000.00
CRGO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -6227000.00
CRGO income_statement (quarterly, 2026-03-31) — Total Unusual Items: -1789000.00
CRGO income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -1789000.00
CRGO balance_sheet (quarterly, 2026-03-31) — Working Capital: 14514000.00
CRGY balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 75827000.00
CRGY balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 75827000.00
CRGY cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: -8794000.00
CRGY balance_sheet (annual, 2021-12-31) — Goodwill: 76564000.00
CRGY balance_sheet (annual, 2021-12-31) — Goodwill And Other Intangible Assets: 76564000.00
CRGY cash_flow (annual, 2021-12-31) — Income Tax Paid Supplemental Data: 562000.00
CRGY balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 15415000.00
CRGY balance_sheet (annual, 2021-12-31) — Long Term Equity Investment: 15415000.00
CRGY income_statement (annual, 2021-12-31) — Net Income Extraordinary: 339168000.00
CRGY income_statement (annual, 2022-12-31) — +Operating Expense: 1132038000.00
CRGY income_statement (annual, 2022-12-31) — +Total Revenue: 3057065000.00
CRGY balance_sheet (annual, 2022-12-31) — Accounts Payable: 144565000.00
CRGY balance_sheet (annual, 2022-12-31) — Accounts Receivable: 459752000.00
CRGY balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -2167135000.00
CRGY balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 804587000.00
CRGY cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 142902000.00
CRGY income_statement (annual, 2022-12-31) — Average Dilution Earnings: 515000.00
CRGY income_statement (annual, 2022-12-31) — Basic Average Shares: 168722000.00
CRGY income_statement (annual, 2022-12-31) — Basic EPS: 2.20
CRGY cash_flow (annual, 2022-12-31) — Beginning Cash Position: 135117000.00
CRGY cash_flow (annual, 2022-12-31) — Capital Expenditure: -1219327000.00
CRGY balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 69128000.00
CRGY balance_sheet (annual, 2022-12-31) — Capital Stock: 17000.00
CRGY balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 0.00
CRGY balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 0.00
CRGY cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -27509000.00
CRGY cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -7841000.00
CRGY cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1124344000.00
CRGY cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 1012372000.00
CRGY cash_flow (annual, 2022-12-31) — Change In Account Payable: 139664000.00
CRGY cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -12530000.00
CRGY cash_flow (annual, 2022-12-31) — Change In Payable: 139664000.00
CRGY cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 139664000.00
CRGY cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -24932000.00
CRGY cash_flow (annual, 2022-12-31) — Change In Receivables: -110460000.00
CRGY cash_flow (annual, 2022-12-31) — Change In Working Capital: -8258000.00
CRGY cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -110460000.00
CRGY cash_flow (annual, 2022-12-31) — Changes In Cash: -119813000.00
CRGY balance_sheet (annual, 2022-12-31) — Common Stock: 17000.00
CRGY cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -27509000.00
CRGY balance_sheet (annual, 2022-12-31) — Common Stock Equity: 848113000.00
CRGY cash_flow (annual, 2022-12-31) — Common Stock Issuance: 0.00
CRGY cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
CRGY income_statement (annual, 2022-12-31) — Cost Of Revenue: 438753000.00
CRGY balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 133131000.00
CRGY balance_sheet (annual, 2022-12-31) — Current Assets: 516739000.00
CRGY balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 61716000.00
CRGY balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 61716000.00
CRGY balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 160775000.00
CRGY balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 160775000.00
CRGY balance_sheet (annual, 2022-12-31) — Current Liabilities: 893749000.00
CRGY cash_flow (annual, 2022-12-31) — Deferred Income Tax: 33178000.00
CRGY cash_flow (annual, 2022-12-31) — Deferred Tax: 33178000.00
CRGY cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 532926000.00
CRGY income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 532926000.00
CRGY balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 63737000.00
CRGY income_statement (annual, 2022-12-31) — Diluted Average Shares: 168969000.00
CRGY income_statement (annual, 2022-12-31) — Diluted EPS: 2.20
CRGY income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 97189000.00
CRGY income_statement (annual, 2022-12-31) — EBIT: 612828000.00
CRGY income_statement (annual, 2022-12-31) — EBITDA: 1145754000.00
CRGY income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 4616000.00
CRGY cash_flow (annual, 2022-12-31) — End Cash Position: 15304000.00
CRGY balance_sheet (annual, 2022-12-31) — Financial Assets: 0.00
CRGY cash_flow (annual, 2022-12-31) — Financing Cash Flow: -7841000.00
CRGY cash_flow (annual, 2022-12-31) — Free Cash Flow: -206955000.00
CRGY cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 574979000.00
CRGY cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -4641000.00
CRGY income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 4641000.00
CRGY income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -676902000.00
CRGY income_statement (annual, 2022-12-31) — General And Administrative Expense: 88006000.00
CRGY balance_sheet (annual, 2022-12-31) — Goodwill: 0.00
CRGY balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 0.00
CRGY balance_sheet (annual, 2022-12-31) — Gross PPE: 7604905000.00
CRGY income_statement (annual, 2022-12-31) — Gross Profit: 2618312000.00
CRGY balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 14878000.00
CRGY income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 142902000.00
CRGY cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 8164000.00
CRGY income_statement (annual, 2022-12-31) — Interest Expense: 95937000.00
CRGY income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 95937000.00
CRGY cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 81920000.00
CRGY balance_sheet (annual, 2022-12-31) — Interest Payable: 11672000.00
CRGY balance_sheet (annual, 2022-12-31) — Invested Capital: 2095671000.00
CRGY cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1124344000.00
CRGY balance_sheet (annual, 2022-12-31) — Investments And Advances: 15038000.00
CRGY cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CRGY cash_flow (annual, 2022-12-31) — Issuance Of Debt: 1584250000.00
CRGY balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 7412000.00
CRGY balance_sheet (annual, 2022-12-31) — Long Term Debt: 1247558000.00
CRGY balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 1254970000.00
CRGY cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 199250000.00
CRGY cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
CRGY balance_sheet (annual, 2022-12-31) — Long Term Provisions: 346868000.00
CRGY balance_sheet (annual, 2022-12-31) — Minority Interest: 2450881000.00
CRGY income_statement (annual, 2022-12-31) — Minority Interests: -383926000.00
CRGY cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CRGY balance_sheet (annual, 2022-12-31) — Net Debt: 1247558000.00
CRGY income_statement (annual, 2022-12-31) — Net Income: 96674000.00
CRGY income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 96674000.00
CRGY income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 480600000.00
CRGY income_statement (annual, 2022-12-31) — Net Income Extraordinary: 0.00
CRGY income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 96674000.00
CRGY income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 96674000.00
CRGY cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 480600000.00
CRGY income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 480600000.00
CRGY income_statement (annual, 2022-12-31) — Net Interest Income: -95937000.00
CRGY cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 215250000.00
CRGY cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 199250000.00
CRGY income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -95937000.00
CRGY cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -195582000.00
CRGY cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 1780000.00
CRGY balance_sheet (annual, 2022-12-31) — Net PPE: 5437770000.00
CRGY cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1126124000.00
CRGY cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 16000000.00
CRGY balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 848113000.00
CRGY balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 147348000.00
CRGY balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 147348000.00
CRGY income_statement (annual, 2022-12-31) — Normalized EBITDA: 2024765000.00
CRGY income_statement (annual, 2022-12-31) — Normalized Income: 914154230.00
CRGY cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1012372000.00
CRGY cash_flow (annual, 2022-12-31) — Operating Gains Losses: 570338000.00
CRGY income_statement (annual, 2022-12-31) — Operating Income: 1486274000.00
CRGY income_statement (annual, 2022-12-31) — Operating Revenue: 3057065000.00
CRGY balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 48282163.00
CRGY balance_sheet (annual, 2022-12-31) — Other Current Assets: 28868000.00
CRGY balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 338066000.00
CRGY income_statement (annual, 2022-12-31) — Other Gand A: -89403000.00
CRGY income_statement (annual, 2022-12-31) — Other Income Expense: -873446000.00
CRGY cash_flow (annual, 2022-12-31) — Other Non Cash Items: -777377000.00